Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helen Hanson

Showing results (21-30 of 85) with videos related to

Pageof 9
Sort By:
Journal of Medical Genetics|May 30, 2024
Carrier testing for partners of <i>MUTYH</i> variant carriers: UK Cancer Genetics Group recommendationsTerri Patricia McVeigh, Fiona Lalloo, Kevin J Monahan, et al.
Journal of Medical Genetics|May 2, 2024
Challenges in developing and implementing international best practice guidance for intermediate-risk variants in cancer susceptibility genes: <i>APC</i> c.3920T>A p.(Ile1307Lys) as an exemplarTerri Patricia McVeigh, Fiona Lalloo, Ian M Frayling, et al.
Familial Cancer|June 25, 2021
Surveillance recommendations for DICER1 pathogenic variant carriers: a report from the SIOPE Host Genome Working Group and CanGene-CanVar Clinical Guideline Working GroupJette J Bakhuizen, Helen Hanson, Karin van der Tuin, et al.
Journal of Medical Genetics|April 26, 2019
Structural Aberrations with Secondary Implications (SASIs): consensus recommendations for reporting of cancer susceptibility genes identified during analysis of Copy Number Variants (CNVs)Sabrina Talukdar, Lara Hawkes, Helen Hanson, et al.
Journal of Medical Genetics|June 24, 2020
UKCGG Consensus Group guidelines for the management of patients with constitutional <i>TP53</i> pathogenic variantsHelen Hanson, Angela F Brady, Gillian Crawford, et al.
Psycho-Oncology|September 23, 2024
'I Live With Lynch. Cancer Worry Ebbs Into the Background, Then Something Brings It to the Fore.' A Qualitative Interview Study Exploring How Lynch Syndrome Carriers Make Sense of Their Cancer Risks and Implications to Support Decision MakingKelly Kohut, Kate Morton, Lesley Turner, et al.
Journal of Medical Genetics|December 5, 2023
Co-design of patient information leaflets for germline predisposition to cancer: recommendations for clinical practice from the UK Cancer Genetics Group (UKCGG), Cancer Research UK (CRUK) funded CanGene-CanVar Programme and the Association of Genetic Nurse Counsellors (AGNC)Kelly Kohut, Beverley Speight, Julie Young, et al.
Musculoskeletal Care|December 17, 2016
Patient and researcher perspectives on facilitating patient and public involvement in rheumatology researchJudith Pollock, Karim Raza, Arthur G Pratt, et al.
European Journal of Human Genetics : EJHG|August 22, 2023
Clinical practice guidelines for the diagnosis and surveillance of BAP1 tumour predisposition syndromeFiona Lalloo, Anju Kulkarni, Cindy Chau, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|May 9, 2024
Breast cancer risk assessment for prescription of menopausal hormone therapy in women with a family history of breast cancer: an epidemiological modelling studyCatherine Huntley, Bethany Torr, Grace Kavanaugh, et al.
Pageof 9

Showing results (21-30 of 85) with videos related to

Sort By:
Pageof 9
Journal of Medical Genetics|May 30, 2024
Carrier testing for partners of <i>MUTYH</i> variant carriers: UK Cancer Genetics Group recommendationsTerri Patricia McVeigh, Fiona Lalloo, Kevin J Monahan, et al.
Journal of Medical Genetics|May 2, 2024
Challenges in developing and implementing international best practice guidance for intermediate-risk variants in cancer susceptibility genes: <i>APC</i> c.3920T>A p.(Ile1307Lys) as an exemplarTerri Patricia McVeigh, Fiona Lalloo, Ian M Frayling, et al.
Familial Cancer|June 25, 2021
Surveillance recommendations for DICER1 pathogenic variant carriers: a report from the SIOPE Host Genome Working Group and CanGene-CanVar Clinical Guideline Working GroupJette J Bakhuizen, Helen Hanson, Karin van der Tuin, et al.
Journal of Medical Genetics|April 26, 2019
Structural Aberrations with Secondary Implications (SASIs): consensus recommendations for reporting of cancer susceptibility genes identified during analysis of Copy Number Variants (CNVs)Sabrina Talukdar, Lara Hawkes, Helen Hanson, et al.
Journal of Medical Genetics|June 24, 2020
UKCGG Consensus Group guidelines for the management of patients with constitutional <i>TP53</i> pathogenic variantsHelen Hanson, Angela F Brady, Gillian Crawford, et al.
Psycho-Oncology|September 23, 2024
'I Live With Lynch. Cancer Worry Ebbs Into the Background, Then Something Brings It to the Fore.' A Qualitative Interview Study Exploring How Lynch Syndrome Carriers Make Sense of Their Cancer Risks and Implications to Support Decision MakingKelly Kohut, Kate Morton, Lesley Turner, et al.
Journal of Medical Genetics|December 5, 2023
Co-design of patient information leaflets for germline predisposition to cancer: recommendations for clinical practice from the UK Cancer Genetics Group (UKCGG), Cancer Research UK (CRUK) funded CanGene-CanVar Programme and the Association of Genetic Nurse Counsellors (AGNC)Kelly Kohut, Beverley Speight, Julie Young, et al.
Musculoskeletal Care|December 17, 2016
Patient and researcher perspectives on facilitating patient and public involvement in rheumatology researchJudith Pollock, Karim Raza, Arthur G Pratt, et al.
European Journal of Human Genetics : EJHG|August 22, 2023
Clinical practice guidelines for the diagnosis and surveillance of BAP1 tumour predisposition syndromeFiona Lalloo, Anju Kulkarni, Cindy Chau, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|May 9, 2024
Breast cancer risk assessment for prescription of menopausal hormone therapy in women with a family history of breast cancer: an epidemiological modelling studyCatherine Huntley, Bethany Torr, Grace Kavanaugh, et al.
Pageof 9